Pinto; Ivan Leo
Patent Applications and Registrations
Patent applications and USPTO patent grants for Pinto; Ivan Leo.The latest application filed is for "novel compounds".
Company Profile
0.15.32
- Pinto; Ivan Leo - Essex GB
- PINTO; Ivan Leo - Stevenage GB
- Pinto; Ivan Leo - Harlow GB
- Pinto; Ivan Leo - Hertfordshire GB
- Pinto, Ivan Leo - Sutton GB
Patent Activity
| Patent | Date |
|---|---|
| Compounds Grant 9,266,841 - Hickey , et al. February 23, 2 | 2016-02-23 |
| Novel Compounds App 20150080418 - PINTO; Ivan Leo ; et al. | 2015-03-19 |
| Novel Compounds App 20150045375 - HICKEY; Deirdre Mary Bernadette ; et al. | 2015-02-12 |
| Compounds Grant 8,871,775 - Hickey , et al. October 28, 2 | 2014-10-28 |
| Novel Compounds App 20130150383 - PINTO; Ivan Leo ; et al. | 2013-06-13 |
| HM74 receptor agonists:xanthine derivatives, corresponding pharmaceutical compositions, treatment methods and processes Grant 8,394,808 - Pinto , et al. March 12, 2 | 2013-03-12 |
| Compounds Grant 8,268,839 - Pinto , et al. September 18, 2 | 2012-09-18 |
| Novel Compounds App 20120172378 - HICKEY; Deirdre Mary Bernadette ; et al. | 2012-07-05 |
| Xanthine derivatives as selective HM74A agonists Grant 8,143,264 - Hatley , et al. March 27, 2 | 2012-03-27 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20110257205 - HATLEY; Richard Jonathan Daniel ; et al. | 2011-10-20 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20100179128 - Hatley; Richard Jonathan Daniel ; et al. | 2010-07-15 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20100168122 - Hatley; Richard Jonathan Daniel ; et al. | 2010-07-01 |
| Novel Compounds App 20100160354 - Pinto; Ivan Leo ; et al. | 2010-06-24 |
| 5,6-trimethylenepyrimidin-4-one Compounds App 20100144765 - HICKEY; Deidre Mary Bernadette ; et al. | 2010-06-10 |
| Xanthines with HM74A receptor activity Grant 7,713,982 - Pinto May 11, 2 | 2010-05-11 |
| 5,6-trimethylenepyrimidin-4-one compounds Grant 7,652,019 - Hickey , et al. January 26, 2 | 2010-01-26 |
| Novel Compounds App 20100010021 - Pinto; Ivan Leo ; et al. | 2010-01-14 |
| Pyrimidine compounds Grant 7,638,520 - Hickey , et al. December 29, 2 | 2009-12-29 |
| Xanthine Derivatives with HM74A Receptor Activity App 20090209561 - Hatley; Richard Jonathan Daniel ; et al. | 2009-08-20 |
| 5,6-Trimethylenepyrimidin-4-one compounds App 20090170877 - Hickey; Deirdre Mary Bernadette ; et al. | 2009-07-02 |
| Novel Compounds App 20090118313 - Hickey; Deirdre Mary Bernadette ; et al. | 2009-05-07 |
| Pyrimidinone derivatives and their use in the treatment of atherosclerosis Grant 7,462,620 - Hickey , et al. December 9, 2 | 2008-12-09 |
| Anthranilic Acid Derivatives As Hm74A Receptor Agonists App 20080221108 - Hatley; Richard ; et al. | 2008-09-11 |
| Anthranilic Acid Derivatives Active as the Hm74a Receptor App 20080214638 - Mason; Andrew McMurtrie ; et al. | 2008-09-04 |
| 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists App 20080200468 - Simpson; Juliet Kay ; et al. | 2008-08-21 |
| Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia App 20080139565 - Campbell; Matthew ; et al. | 2008-06-12 |
| Anthranilic acid derivatives and their use as activators of the hm74a receptor App 20070191378 - Campbell; Matthew ; et al. | 2007-08-16 |
| Pyridinone derivatives for treatment of atherosclerosis Grant 7,235,566 - Hickey , et al. June 26, 2 | 2007-06-26 |
| Medicaments with hm74a receptor activity App 20070135456 - Pinto; Ivan Leo ; et al. | 2007-06-14 |
| Pyrimidine compounds App 20070123549 - Hickey; Deirdre Mary Bernadette ; et al. | 2007-05-31 |
| Pyrimidinone derivatives and their use in the treatment of atherosclerosis Grant 7,169,924 - Elliott , et al. January 30, 2 | 2007-01-30 |
| Pyrimidinone Derivatives and Their Use in the Treatment of Atherosclerosis App 20060241126 - Elliott; Richard Leonard ; et al. | 2006-10-26 |
| Pyrimidinone compounds Grant 7,115,616 - Fenwick , et al. October 3, 2 | 2006-10-03 |
| Heterocyclic derivatives of glycinamide and their medical use App 20050043335 - Elliott, Richard Leonard ; et al. | 2005-02-24 |
| Novel compounds App 20050033052 - Leach, Colin Andrew ; et al. | 2005-02-10 |
| Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors App 20050020832 - Fell, Stephen Christopher Martin ; et al. | 2005-01-27 |
| Pyridinone derivatives for treatment of atherosclerosis App 20050014793 - Hickey, Deirdre Mary Bernadette ; et al. | 2005-01-20 |
| Pyrimidinone compounds App 20040167142 - Fenwick, Ashley Edward ; et al. | 2004-08-26 |
| Novel Compounds App 20040097525 - Hickey, Deirdre Mary Bernadette ; et al. | 2004-05-20 |
| Pyridinone derivatives for treatment of atherosclerosis App 20040063753 - Hickey, Deirdre Mary Bernadette ; et al. | 2004-04-01 |
| Pyrimidinone derivatives and their use in the treatment of atherosclerosis App 20040058941 - Elliott, Richard Leonard ; et al. | 2004-03-25 |
| Compounds Grant 6,649,619 - Hickey , et al. November 18, 2 | 2003-11-18 |
| Pyrimidinone compounds and pharmaceutical compositions containing them App 20020120139 - Hickey, Deirdre Mary Bernadette ; et al. | 2002-08-29 |
| Novel compounds App 20020103213 - Hickey, Deirdre Mary Bernadette ; et al. | 2002-08-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 